387409009: Scopolamine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Acetylcholine receptor antagonist\Muscarinic receptor antagonist\Scopolamine (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\...

\Antispasmodic (substance)\Scopolamine (substance)

\Acetylcholine receptor antagonist\Muscarinic receptor antagonist\Scopolamine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic cyclic compound\Heterocyclic compound\...

\Tropane (substance)\Tropane alkaloid (substance)\Scopolamine (substance)

\Alkaloid (substance)\Tropane alkaloid (substance)\Scopolamine (substance)

\Aza compound (substance)\Azabicyclo compound (substance)\Tropane (substance)\Tropane alkaloid (substance)\Scopolamine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Scopolamine (substance)	Is a	Muscarinic receptor antagonist	true	Inferred relationship	Some
Scopolamine (substance)	Is a	cycloplegisk middel	false	Inferred relationship	Some
Scopolamine (substance)	Is a	Antispasmodic (substance)	true	Inferred relationship	Some
Scopolamine (substance)	Is a	Tropane alkaloid (substance)	true	Inferred relationship	Some
Scopolamine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Muscarinic receptor antagonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Scopolamine measurement	Component	True	Scopolamine (substance)	Inferred relationship	Some	1
Hyoscine hydrobromide [central nervous system use]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
Hyoscine 600micrograms tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
Hyoscine 500micrograms/72hours transdermal patch	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
hyoscinhydrobromid 1 mg/72 timer depotplaster	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
Hyoscine hydrobromide [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
hyoscinhydrobromid 0,25 % øjendråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
Hyoscine hydrobromide [anesthesia]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
hyoscinhydrobromid 0,125 % øjendråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
hyoscinhydrobromid 0,5 % øjendråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
Hyoscine hydrobromide 150 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
hyoscinhydrobromid 400 µg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
hyoscinhydrobromid 600 µg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
scopolamin plaster a 1,5 mg/enhed	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
scopolamin 0,5 mg/24-timer plaster	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
Ophthalmic hyoscine hydrobromide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
Scopolamine hydrobromide (substance)	Is a	False	Scopolamine (substance)	Inferred relationship	Some
Hyoscine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
Hyoscine butylbromide	Is a	False	Scopolamine (substance)	Inferred relationship	Some
Product containing scopolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Methscopolamine (substance)	Is a	False	Scopolamine (substance)	Inferred relationship	Some
hyoscinhydrobromid 0,25 % øjendråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
hyoscinhydrobromid 0,125 % øjendråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
hyoscinhydrobromid 0,5 % øjendråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
Hyoscine hydrobromide [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
scopolamin til oftalmisk anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
Product containing scopolamine in topical dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine (substance)	Inferred relationship	Some
Product containing scopolamine in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Hyoscine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Accidental poisoning caused by hyoscine (disorder)	Causative agent	True	Scopolamine (substance)	Inferred relationship	Some	1
forgiftning med hyoscin, uvist med hvilken hensigt	Causative agent	False	Scopolamine (substance)	Inferred relationship	Some	1
Intentional hyoscine poisoning	Causative agent	True	Scopolamine (substance)	Inferred relationship	Some	1
Poisoning by hyoscine	Causative agent	True	Scopolamine (substance)	Inferred relationship	Some	1
Hyoscine methonitrate	Is a	False	Scopolamine (substance)	Inferred relationship	Some
Allergy to hyoscine	Causative agent	False	Scopolamine (substance)	Inferred relationship	Some	2
Hyoscine butylbromide	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Scopolamine (substance)	Inferred relationship	Some
Scopolamine hydrobromide (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Scopolamine (substance)	Inferred relationship	Some
Hyoscine methonitrate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Scopolamine (substance)	Inferred relationship	Some
Product containing scopolamine in transdermal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	3
Product containing atropine and hyoscyamine and scopolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	3
Hyoscine 13.889 microgram/hour prolonged-release transdermal patch	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Scopolamine (substance)	Inferred relationship	Some	1
Hyoscine 13.889 microgram/hour prolonged-release transdermal patch	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Scopolamine (substance)	Inferred relationship	Some	1
overdosis af hyoscin, uvist med hvilken hensigt	Causative agent	False	Scopolamine (substance)	Inferred relationship	Some	1
Accidental hyoscine overdose	Causative agent	True	Scopolamine (substance)	Inferred relationship	Some	1
Intentional hyoscine overdose	Causative agent	True	Scopolamine (substance)	Inferred relationship	Some	1
Hyoscine overdose	Causative agent	True	Scopolamine (substance)	Inferred relationship	Some	1
Product containing papaveretum and scopolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Product containing scopolamine in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Product containing scopolamine in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Product containing only atropine and hyoscyamine and scopolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	3
Product containing only papaveretum and scopolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Hyoscine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Hyoscine only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Product containing only scopolamine in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Hyoscine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Product containing only scopolamine in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Product containing only scopolamine in transdermal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Atropine and hyoscine and hyoscyamine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	3
Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Scopolamine (substance)	Inferred relationship	Some	1
Allergy to hyoscine	Causative agent	True	Scopolamine (substance)	Inferred relationship	Some	1
Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Scopolamine (substance)	Inferred relationship	Some	1
Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Scopolamine (substance)	Inferred relationship	Some	1
Hyoscine (as hyoscine hydrobromide) 5 mg/mL eye solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Scopolamine (substance)	Inferred relationship	Some	1
Hyoscine adverse reaction	Causative agent	True	Scopolamine (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461587015	Scopolamine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481501014	Scopolamine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1492053010	Hyoscine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3264391000005114	scopolamin	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)